Emergent BioSolutions
EBS
#6762
Rank
ยฃ0.47 B
Marketcap
ยฃ8.94
Share price
-1.24%
Change (1 day)
30.07%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): ยฃ0.12 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are ยฃ0.75 Billion. In 2024 the company made an earning of -ยฃ54 Million, an increase over its 2023 earnings that were of -ยฃ0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.12 B-332.5%
2024 -ยฃ54 Million-88.82%
2023 -ยฃ0.49 Billion242.73%
2022 -ยฃ0.15 Billion-153.8%
2021 ยฃ0.26 B-20.43%
2020 ยฃ0.32 B278.02%
2019 ยฃ87.11 M27.11%
2018 ยฃ68.53 M-27.12%
2017 ยฃ94.04 M17.21%
2016 ยฃ80.23 M0.45%
2015 ยฃ79.87 M73.51%
2014 ยฃ46.03 M41.36%
2013 ยฃ32.56 M35.2%
2012 ยฃ24.08 M0.4%
2011 ยฃ23.99 M-56.46%
2010 ยฃ55.1 M76.73%
2009 ยฃ31.18 M32.94%
2008 ยฃ23.45 M-5.62%
2007 ยฃ24.85 M
2005 ยฃ35.98 M269.89%
2004 ยฃ9.72 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
ยฃ17.34 B 13,868.54%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
ยฃ67.8 M-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ7.00 B 5,539.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-ยฃ0.2 Billion-255.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.90 B 7,069.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.33 B 971.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
-ยฃ9.29 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA